OraSure Technologies, Inc. Logo
OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference
February 24, 2021 16:01 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and...
OraSure Technologies, Inc. Logo
2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET
February 18, 2021 06:00 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 fourth quarter financial results and...
OraSure Technologies, Inc. Logo
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test
January 29, 2021 06:00 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 29, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and...
OraSure Technologies, Inc. Logo
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing
January 28, 2021 06:00 ET | OraSure Technologies, Inc.
OTTAWA, Jan. 28, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical...
OraSure Technologies, Inc. Logo
OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program
January 26, 2021 07:57 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 26, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and...
OraSure Technologies, Inc. Logo
OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencing Platform
January 21, 2021 06:00 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 21, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and...
OraSure Technologies, Inc. Logo
OraSure Technologies Announces 2021 Annual Meeting Date
January 08, 2021 06:00 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 08, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2021 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT...
OraSure Technologies, Inc. Logo
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 06:00 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and...
OraSure Technologies, Inc. Logo
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test
December 23, 2020 06:00 ET | OraSure Technologies, Inc.
OTTAWA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical...
OraSure Technologies, Inc. Logo
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test
December 21, 2020 16:01 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today disclosed that the U.S....